Source:http://linkedlifedata.com/resource/pubmed/id/11289058
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions |
umls-concept:C0001898,
umls-concept:C0011847,
umls-concept:C0011860,
umls-concept:C0237401,
umls-concept:C0332281,
umls-concept:C0332307,
umls-concept:C0683598,
umls-concept:C0683971,
umls-concept:C0684336,
umls-concept:C1256369,
umls-concept:C1314939,
umls-concept:C1527148,
umls-concept:C1555721,
umls-concept:C1706204
|
| pubmed:issue |
4
|
| pubmed:dateCreated |
2001-4-5
|
| pubmed:abstractText |
The allele frequencies for a Pro12-->Ala substitution in peroxisome proliferator-activated receptor-gamma differ among ethnic groups, and its relationship with diabetes and associated diseases is controversial. The prevalence of this polymorphism and its effects on clinical characteristics have now been evaluated with a large number of Japanese individuals with type 2 diabetes (n = 2,201) and normal control subjects (n = 1,212) recruited by 10 institutions located in seven different cities in Japan. The allele frequency for the Ala12 variant was significantly lower in the type 2 diabetic group than in the control group (2.39 vs. 4.13%, P = 0.000054). However, compared with subjects without the Ala12 variant, the diabetic subjects with this variant exhibited a significantly higher serum concentration of total cholesterol (P = 0.001), manifested a reduced capacity for insulin secretion as evaluated by homeostasis model assessment (P = 0.007), and tended to possess a higher level of HbA1c. These data suggest that the Ala12 variant is associated with a reduced risk for the development of diabetes in the general population, but that it may be also a risk factor for insulin deficiency and disease severity in individuals with type 2 diabetes.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0012-1797
|
| pubmed:author |
pubmed-author:AwataTT,
pubmed-author:GotodaTT,
pubmed-author:HanafusaTT,
pubmed-author:HaraKK,
pubmed-author:IkegamiHH,
pubmed-author:InoueII,
pubmed-author:IwamotoYY,
pubmed-author:IwasakiNN,
pubmed-author:KadowakiTT,
pubmed-author:KasugaMM,
pubmed-author:KawaguchiYY,
pubmed-author:MaedaEE,
pubmed-author:MatsutaniAA,
pubmed-author:MoriHH,
pubmed-author:NanjoKK,
pubmed-author:OkaYY,
pubmed-author:SankeTT,
pubmed-author:SeinoSS,
pubmed-author:SeinoYY,
pubmed-author:TakedaJJ,
pubmed-author:YamadaNN,
pubmed-author:YamagataKK,
pubmed-author:YasudaKK,
pubmed-author:YokooTT
|
| pubmed:issnType |
Print
|
| pubmed:volume |
50
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
891-4
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:11289058-Adult,
pubmed-meshheading:11289058-Aged,
pubmed-meshheading:11289058-Amino Acid Substitution,
pubmed-meshheading:11289058-Diabetes Mellitus,
pubmed-meshheading:11289058-Diabetes Mellitus, Type 2,
pubmed-meshheading:11289058-Female,
pubmed-meshheading:11289058-Genetic Predisposition to Disease,
pubmed-meshheading:11289058-Humans,
pubmed-meshheading:11289058-Insulin,
pubmed-meshheading:11289058-Male,
pubmed-meshheading:11289058-Middle Aged,
pubmed-meshheading:11289058-Receptors, Cytoplasmic and Nuclear,
pubmed-meshheading:11289058-Transcription Factors
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
The Pro12 -->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes.
|
| pubmed:affiliation |
Second Department of Internal Medicine, Kobe University School of Medicine, Japan.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|